Promaxo is commercializing customer-centric MRI systems and robotic guidance tools for live diagnosis and treatment in a physician's office.
Promaxo is a medical technology company that develops and commercializes customer-centric MRI systems, and MRI compatible robotics and machine learning based technologies that enhance patients' lives and redefine the standard of care. Using proprietary technologies protected by 55+ patents, the Company is bringing the first MRI and robotics guidance system for in-office use. Products in the pipeline include disposables and an AI-based tissue characterization system.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
May 28, 2020 | Series B | $10.97M | 1 | Kineticos Disruptor Fund | — | Detail |
Apr 11, 2018 | Series A | $2.20M | 2 | — | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
Kineticos Disruptor Fund | Yes | Series B |
RocSon Medtech Fund | — | Series A |
Almond Tree Capital Fund | — | Series A |